Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
Thrombin activatable fibrinolysis inhibitor (TAFI), a proenzyme, is converted to a potent attenuator of the fibrinolytic system upon activation by thrombin, plasmin, or the thrombin/thrombomodulin complex. Since TAFI forms a molecular link between coagulation and fibrinolysis and plays a potential r...
Main Authors: | Machteld Sillen, Paul J. Declerck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/7/3670 |
Similar Items
-
The Relation Between Serum P-selectin, Thrombin-activatable Fibrinolysis Inhibitor Levels, and Carotid Artery Intima-media Thickness in Acute Ischemic Stroke
by: Dilek Yılmaz, et al.
Published: (2020-03-01) -
Regulation of the Gene Encoding Thrombin-Activable Fibrinolysis Inhibitor in Non-Hepatic Cells
by: LIN, H-H JOELLEN
Published: (2011) -
Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients
by: Juan Marta-Enguita, et al.
Published: (2021-02-01) -
Perioperative Coagulopathy in Patients with Normal Preoperative Coagulation Screen: A Couple of Coagulopathic Clinical Case Conundrums
by: Joseph N. Monteiro, et al.
Published: (2020-06-01) -
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?
by: Karen Claesen, et al.
Published: (2021-01-01)